West nile virus screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{West nile virus}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{WikiDoc Help Menu}} {{WS}} Category:Disease Category:Infectious disease Category:Neurology" |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
==Screening== | |||
Commercial kits for human serologic diagnosis of WNV infection are currently in development. Until these kits are available, the CDC-defined IgM and IgG ELISA should be the front-line tests for serum and CSF.46-48 These ELISA tests are the most sensitive screening assays available. The HI and indirect immunofluorescent antibody (IFA) test may also be used to screen samples for flavivirus antibodies. | |||
[http://www.cdc.gov/ncidod/dvbid/westnile/resources/wnv-guidelines-aug-2003.pdf] | |||
==References== | ==References== | ||
Revision as of 19:25, 2 February 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Screening
Commercial kits for human serologic diagnosis of WNV infection are currently in development. Until these kits are available, the CDC-defined IgM and IgG ELISA should be the front-line tests for serum and CSF.46-48 These ELISA tests are the most sensitive screening assays available. The HI and indirect immunofluorescent antibody (IFA) test may also be used to screen samples for flavivirus antibodies. [2]